DeNovX is pleased to announce the establishment of a collaboration with scientists in the Center for Structural Genomics of Infectious Diseases (CSGID) at Argonne National Laboratory. This effort is funded through a Phase II SBIR award to DeNovX, and it will provide an opportunity to investigate the crystallization of high impact, infectious disease-related proteins produced in the CSGID pipeline. Once crystalline, these proteins will be characterized at the Midwest Center for Structural Genomics’ beamline at the Advanced Photon source.